Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study.
Zainab M A Al RadiFemke M PrinsValerie CollijArnau Vich VilaEleonora A M FestenGerard DijkstraRinse K WeersmaMarjolein A Y KlaassenRanko GacesaPublished in: Inflammatory bowel diseases (2024)
The gut microbiome is a potential biomarker for therapy intensification in IBD patients and personalized management strategies. Further research should validate our findings in other cohorts to enhance the generalizability of these results.